Opthea reports promising 12-week data from phase Ib study of OPT-302 in DME Oct. 29, 2018 No Comments
Oyster Point's OC-01 and OC-02 demonstrate improvement in Schirmer's score for dry eye disease Oct. 25, 2018 No Comments
Mitotech initiates phase III study of SkQ1 ophthalmic solution in patients with dry eye Oct. 23, 2018 No Comments
First phase III results from the SAkuraSky study of satralizumab in NMOSD patients Oct. 19, 2018 No Comments
GenSight reports 72-week data from REVERSE phase III trial of GS-010 in LHON Oct. 18, 2018 No Comments
Modest improvements to visual acuity observed following retinal gene therapy for choroideremia Oct. 17, 2018 No Comments
RSS